Daily Margin Trading Facility book for Alkem Laboratories across NSE and BSE, from 01 Aug 2017. All figures in ₹ crore, derived from exchange public disclosures.
What is Alkem Laboratories’s MTF book?
Alkem Laboratories Limited (ALKEM) has ₹28 crore funded under Margin Trading Facility across NSE and BSE as of 23 Oct 2026 — 0.02% of India’s MTF book, ranking #885. Over 1M (the last 30 trading days) the funded value has fallen 13.1%, with the number of shares under margin down 12.6%.
Share of free float on margin, month by month
Shares under margin at each month-end as a share of free-float shares, using that month-end’s share count and the free-float filing public at the time. It counts shares, not value, so a price move does not move it by itself.
View as table: share of free float on margin24 months
| Month-end | % of free float |
|---|---|
| 23 Oct 2026 | 0.085% |
| 30 Sep 2026 | 0.084% |
| 31 Aug 2026 | 0.087% |
| 31 Jul 2026 | 0.058% |
| 29 Jun 2026† | 0.066% |
| 29 May 2026 | 0.062% |
| 30 Apr 2026 | 0.057% |
| 19 Mar 2026† | 0.042% |
| 24 Feb 2026† | 0.043% |
| 25 Nov 2025† | 0.042% |
| 31 Oct 2025 | 0.041% |
| 30 Sep 2025 | 0.048% |
| 29 Aug 2025 | 0.068% |
| 31 Jul 2025 | 0.114% |
| 30 Jun 2025 | 0.186% |
| 30 May 2025 | 0.105% |
| 30 Apr 2025 | 0.107% |
| 28 Mar 2025 | 0.064% |
| 28 Feb 2025 | 0.088% |
| 31 Jan 2025 | 0.076% |
| 05 Jul 2024† | 0.106% |
| 27 Jun 2024† | 0.100% |
| 03 May 2024† | 0.096% |
| 30 Apr 2024 | 0.093% |
† Not the month’s last trading day: the last day the stock was in the archive that month (before 11 Nov 2025 the archive kept only the 500 largest positions).
Dated events
- 01 Aug 2017First recorded in the MTF book
NSE & BSE split
MTF vs Price
Price and liquidity
Book, shares and price by window
| Window | Book Δ | Book % | Shares | Price | Reading |
|---|---|---|---|---|---|
| 1D | −₹0 | −1.8% | −1.8% −917 | −1.3% | unwinding as it falls |
| 10D | +₹3 | +10.3% | +11.5% +5,275 | −5.8% | building as it falls |
| 1M | −₹4 | −13.1% | −12.6% −7,344 | −4.5% | unwinding as it falls |
| 3M | not enough history | ||||
| 6M | +₹13 | +83.5% | +86.6% +23,678 | −10.4% | building as it falls |
| 1Y | +₹15 | +114.6% | +114.6% +27,237 | −10.6% | building as it falls |
Shares under margin
Rank trajectory
ALKEM — last 30 trading days
| Date | Combined (₹ Cr) | Day Δ (₹ Cr) | % of book | Rank |
|---|---|---|---|---|
| 23 Oct 2026 | 28 | −₹0 | 0.02% | 885 |
| 22 Oct 2026 | 28 | +₹0 | 0.02% | 884 |
| 21 Oct 2026 | 28 | +₹0 | 0.02% | 893 |
| 19 Oct 2026 | 28 | +₹0 | 0.02% | 899 |
| 16 Oct 2026 | 28 | +₹1 | 0.02% | 906 |
| 15 Oct 2026 | 27 | +₹1 | 0.02% | 916 |
| 14 Oct 2026 | 26 | +₹0 | 0.02% | 936 |
| 13 Oct 2026 | 26 | −₹0 | 0.02% | 938 |
| 12 Oct 2026 | 26 | +₹1 | 0.02% | 936 |
| 09 Oct 2026 | 25 | −₹0 | 0.02% | 955 |
| 08 Oct 2026 | 25 | −₹1 | 0.02% | 950 |
| 07 Oct 2026 | 26 | −₹1 | 0.02% | 934 |
| 06 Oct 2026 | 27 | −₹1 | 0.02% | 921 |
| 05 Oct 2026 | 28 | +₹0 | 0.02% | 905 |
| 01 Oct 2026 | 27 | −₹0 | 0.02% | 914 |
| 30 Sep 2026 | 28 | +₹0 | 0.02% | 912 |
| 29 Sep 2026 | 27 | −₹0 | 0.02% | 920 |
| 28 Sep 2026 | 28 | −₹1 | 0.02% | 912 |
| 25 Sep 2026 | 28 | +₹0 | 0.02% | 894 |
| 24 Sep 2026 | 28 | +₹0 | 0.02% | 903 |
| 23 Sep 2026 | 28 | −₹1 | 0.02% | 906 |
| 22 Sep 2026 | 29 | +₹0 | 0.02% | 884 |
| 21 Sep 2026 | 29 | +₹0 | 0.02% | 886 |
| 18 Sep 2026 | 29 | −₹1 | 0.02% | 886 |
| 17 Sep 2026 | 29 | −₹1 | 0.02% | 877 |
| 16 Sep 2026 | 30 | +₹0 | 0.02% | 863 |
| 15 Sep 2026 | 30 | −₹1 | 0.02% | 866 |
| 11 Sep 2026 | 32 | −₹0 | 0.02% | 848 |
| 10 Sep 2026 | 32 | +₹0 | 0.02% | 847 |
| 09 Sep 2026 | 32 | — | 0.02% | 847 |
ALKEM within Health Technology
| # | Stock | MTF book (₹ Cr) | % of sector | % of free float | Book, 1M |
|---|---|---|---|---|---|
| 51 | WINDLASWindlas Biotech | ₹31 | 0.5% | 4.36% | +5.7% |
| 52 | AARTIDRUGSAarti Drugs | ₹31 | 0.5% | 1.73% | +1.3% |
| 53 | ALKEMAlkem Laboratories | ₹28 | 0.4% | 0.09% | −13.1% |
| 54 | ASTRAZENAstraZeneca Pharma India | ₹27 | 0.4% | 0.57% | −13.8% |
| 55 | RUBICONRubicon Research | ₹26 | 0.4% | 0.25% | −15.6% |
